13 Sep 2018

CLEAR Advises Department of Health and MHRA on Definition of Cannabis-Derived Medicinal Products.

Last week, CLEAR was invited to participate in a teleconference with representatives of the Department of Health and Social Care (DHSC) and the Medicines and Healthcare products Regulatory Agency (MHRA). This followed our written submissions made over the last few weeks. The teleconference included two representatives from each party. The DHSC was represented by the Medicines Pharmacy and Industry section. The MHRA was represented by the Licensing Division. CLEAR has now submitted a summary of all the advice offered which is reproduced...